Introduction to New Drug Development
Drug development is a time-consuming and highly capitalized process. According to several studies, the average cost of developing a new drug is approximately 1.3 billion US dollars, and the average cost of developing oncology or immunology drugs can even go up to 2.7 billion US dollars. As for the duration of development, it would take at least 10 years, sometimes even over 2 decades, to develop a new drug.
Our Competitive Advantage
The new drug development team in Aquavan Group has been established since 2019. Our team is consist of PhDs from several renowned University such as Harvard, Imperial College London, and University of Ottawa. We also have research labs located in Taiwan, Canada, USA and France. With our pioneered technology and innovation, we are able to find a candidate compound out of tens of thousands of compounds and finish preclinical trials within a year. Our progress in drug development is 12 times faster, and as a result, 90% lower in development costs comparing to the whole industry.
Focus Areas
The following areas are the ones that we are focusing on:
- Type 2 Diabetes
- Alzheimer’s Disease
- NASH (Nonalcoholic Steatohepatitis)
- TNBC (Triple-negative Breast Cancer)
- AML (Acute Myeloid Leukemia)
- Pancreatic Cancer
- mCRC (Metastatic Colorectal Cancer)
- Sarcopenia
- COPD (Chronic Obstructive Pulmonary Disease)
- Hepetitis B / Hepetitis C
- Macular Degeneration
- DES (Dry Eye Syndrome)
